May 7, 2020

Embrace Experimentation in Biosecurity Governance

Dr. Gerald Epstein and colleagues examine the need to rethink biosecurity governance to address changing technical, social, and political environments.

April 2, 2020

Modernizing biotechnology for the fight against COVID-19 and the future of pandemic response

Alexander Titus, Michelle Rozo, and Diane DiEuliis provide some perspective on the importance of using advanced biotechnology capabilities during the global pandemic.

March 25, 2020

Infodemic

In their article in Inkstick, Dr. Justin Anderson and Ms. Sarah Jacobs Gamberini examine the daunting challenge of attempting to halt the spread of misinformation (erroneous information) and disinformation (deliberately false information) about the coronavirus (COVID-19).

Dec. 13, 2019

Russia's Hypersonic Weapons

While Russian hypersonic weapons could pose problems for U.S. and NATO defense planning, their introduction in the near-term is not likely to fundamentally alter the existing balance of power or the prospects for strategic stability.

Dec. 2, 2019

Synthetic Biology Industry Practices and Opportunities for Biosecurity and Potential Roles for the U.S. Government

This report summarizes discussions with industry representatives about the current and future structure of the synthetic biology industry, perspectives on potential misuse and vulnerabilities of synthetic biology tools and capabilities, and business practices to prevent misuse of tools and to protect industry assets.

Nov. 6, 2019

The death of the INF Treaty has lessons for arms control

In her article in the Bulletin of the Atomic Scientists, Dr. Amy J. Nelson argues that despite the treaty's failure, there is much to be learned from its undoing, as well as from the current state of arms control.

July 23, 2019

Systems-based Approach to Biodefense Policy Analysis

In this article, co-authored by Dr. Diane DiEuliis, the authors describe a systems-based analysis of the US biosecurity and biodefense policy landscape to analyze functional relationships between policies. They identify 2 approaches in US policy for countering biological threats: prevention of theft, diversion, or deliberate malicious use of biological technologies, and development of capabilities and knowledge to assess, detect, monitor, respond to, and attribute biological threats.

July 23, 2019

The INF Treaty: A Spectacular, Inflexible, Time-bound Success

This article discusses the changing dynamics that led first Moscow and then Washington to reevaluate the merit of the INF Treaty. It concludes that the treaty's relative rigidity may play a key role in its undoing and suggests that future arms control negotiations develop more flexible and resilient mechanisms of review, dispute resolution, and verification.

May 22, 2019

Honey, I Shrunk the Lab: Emerging Microfluidics Technology and its Implications for Chemical, Biological, and Nuclear Weapons

Emerging microfluidics technology has significant extant and potential implications for chemical, biological, and nuclear weapons threats. In E&C Research Paper no. 5, Cyrus Jabbari and Philipp Bleek argue that policymakers concerned about CBRN threats have an opportunity to get ahead of, or at least less behind, some of these developments.

Dec. 3, 2018

Deterrence in the 21st Century: Integrating Nuclear and Conventional Force

In this article, published in Strategic Studies Quarterly, Robert Peters, Justin Anderson, and Harrison Menke advocate better integration between nuclear deterrence strategies and nuclear deterrence operations with US conventional defense policy, strategy, and planning processes.